ERBB2 and breast cancer: However, our analysis in the validation set of ER+/HER2- breast cancer patients and the 1100 breast cancers in TCGA dataset demonstrated that the expressions of the ER group genes in the Oncotype Dx signature are substantially correlated with each other, and proliferation markers are strongly correlated with each other, these two clusters being negatively correlated.